Challenger's COE Margin, despite some concerns, actually went up by 10bps from 1H15 to 2H15. They have reintroduced a Care Annuity product called CarePlus, which we noted in a recent report as a major key catalyst for the company given its strong sales potential. In addition to new CarePlus product, there is the new VicSuper white label, and Colonial Platform annuity product – which should add to growth in the September quarter. DRP introduced given move to 100% franking and strong growth rates in business. Funds Management FY15 EBIT of $44m, vs our $45m estimate. Read our full summary here: <a href="" target="_blank" data-event-type="click" data-event="link_click">(VIEW LINK)</a>